Attending #WorldOneHealthCongress? Join the Illumina exclusive lunch session on Sept 22 to discover how #genomics is transforming #OneHealth! π§¬π Hear from top experts, network, & more.
Register now: https://t.co/Wxa3jb1bAB #WOHC2024
Enabling precision genomics #withinfiniumandbeyond. #Infiniumarrays are a scalable and cost-effective tool for analyzing genetic variation across the genome. Learn More: https://t.co/LrOzsY3ciH https://t.co/qIEKKAsLOF
Ready to make a difference against DR-TB? tNGS offers a powerful tool, join our webinar for expert insights on cost-effectiveness, accuracy, utility & tNGS implementation considerations.
Register: https://t.co/VmuxG7AGdj
#drugresistance#NGS#YesWeCanEndTB#EndTB#tNGSforTB
Dr Nicole Chia a Clinical #cytogenetics expert will share her experience and the fundamental steps to consider when launching a molecular cytogenetic service or changing between #microarray platforms. Register now: https://t.co/EfnbsKahHO
https://t.co/1AXlCYObJF
Join our global tuberculosis expert panel for a roundtable discussion at World Conference on Lung Health 2023 #UnionConf2023 and explore the transformative impact of NGS on TB drug resistance detection #YesWeCanEndTB#EndTB
Illumina introduces two new library prep solutions that will help build global genomic and surveillance capabilities and power impactful microbiology research. In the genome era, infectious diseases donβt have to be a disaster. #OneHealth https://t.co/AOF2MHORjQ
Attend this webinar to understand how genomic analysis offers new opportunities for prediction and surveillance of #AMR#AntimicrobialResistance and how this information can be used to mitigate its spread. #OneHealth#publichealth https://t.co/L9KbvlElU4
Illumina is exhibiting (booth number A05) at the PrecisionMed Exhibition and Summit 2023 in Dubai from 24-25 May! Join our session on 24 May, Samih will be speaking about Illumina's Complete Long Read Technology.
#pmes2023
https://t.co/iGWhjWbcnT
"Illumina Complete Long Reads overcomes those pain points and associated costs to make long-read #sequencing accessible and streamlined for genomic labs." β Alex Aravanis, chief technology officer and head of research and product development at Illumina. https://t.co/FXGlI5UVhT
"We have to be mindful that after cancer treatment, kids have a much longer lifetime ahead of them, so developing precision therapies that donβt have off-target effects is much more important in pediatrics.β β Midhat Farooqi, Director of Molecular Oncology https://t.co/6S4F1Dp2f2
Please join @Illumina on 15 April with the Singapore Society of Oncology and @AstraZeneca! Thought leaders will share their experience on the clinical utility of genomics in #precisiononcology at the Precision Oncology Diagnostics Forum. Register now https://t.co/bOUr3Aqeyo
"Now with this test, we are empowering labs in the US to unlock the most comprehensive tumor analysis from a single sample." β Kevin Keegan, VP and GM of Oncology at Illumina https://t.co/Z3ROQiWREu
Tuberculosis (#TB) is a leading global infectious disease killer. In this webinar, 3 accomplished TB researchers will discuss how they advance the fight against TB with the use of #NGS. Join Illumina's #WorldTBday webinar on 24/3! #YesWeCanEndTB https://t.co/Em8H8AdRML
Comprehensive molecular profiling methods are enhancing actionable target discovery in pediatric cancer. Whole genome, transcriptome & methylome profiling are giving researchers an extra dimension of information for a personalized treatment plan https://t.co/O1TB5I6oGO
The ZERO Childhood Cancer program is Australia's most comprehensive advance in delivering precision medicine to children and young people diagnosed with cancer. Learn more at https://t.co/ySzQHX5oWR https://t.co/OYYDy2VkDX
Our team had a lot of fun at @ozsinglecells! We climbed to the highest point in gold coast with a few lucky attendees! Join Illumina as we partner with you to bring your single-cell research to greater heights. See you at the next #OzSingleCell! #skypointclimb
Are you based in New Zealand and looking to generate pilot data? Illumina and Grafton Clinical Genomics is now awarding 1 recipient a chance to receive a 24-sample pilot project using the TSO 500 solution from Illumina. Apply Now. https://t.co/2YE88lgwsq